Indeed, multiple studies have reported that IPF lungs show a shift toward Th2 and Th17 immune responses compared with healthy lungs, implying that the balance between myeloid cell subsets and CD4+ T cell subsets (Th1/Th2/Th17/Treg) is crucial (52–54). The gene discussed is CD4; the disease is idiopathic pulmonary fibrosis.